Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 257,613	$ 143,351
Marketable securities	59,710	73,952
Prepaid expenses and other current assets	5,807	4,036
Total current assets	323,130	221,339
Property and equipment, net	10,953	10,113
Operating right-of-use assets	4,163	4,278
Restricted cash	100	100
Other long-term assets	4,347	4,411
Total assets	342,693	240,241
Current liabilities:
Accounts payable	9,126	14,189
Accrued expenses and other current liabilities	17,656	33,177
Deferred revenue, current	4,015	6,941
Total current liabilities	30,797	54,307
Operating lease liabilities, net of current portion	4,770	4,769
Total liabilities	35,567	59,076
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.0001 par value; 300,000,000 shares authorized at March 31, 2025 and December 31, 2024; 86,955,855 and 64,460,829 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	9	6
Additional paid-in capital	864,530	696,872
Accumulated other comprehensive (loss) income	(3)	57
Accumulated deficit	(557,410)	(515,770)
Total stockholders' equity	307,126	181,165
Total liabilities and stockholders' equity	$ 342,693	$ 240,241